Coexistence of BCR-ABL1 and RUNX1-RUNX1T1 in a de novo AML

Blood. 2021 May 20;137(20):2853. doi: 10.1182/blood.2021011517.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abnormal Karyotype
  • Aged
  • Aneuploidy
  • Biomarkers, Tumor / analysis
  • Blast Crisis / diagnosis
  • Core Binding Factor Alpha 2 Subunit / analysis*
  • Core Binding Factor Alpha 2 Subunit / genetics
  • Diagnosis, Differential
  • Fatal Outcome
  • Fusion Proteins, bcr-abl / analysis*
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Isocitrate Dehydrogenase / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology
  • Male
  • Neoplasm Proteins / genetics
  • RNA, Long Noncoding / analysis*
  • RNA, Long Noncoding / genetics
  • Translocation, Genetic

Substances

  • BCR-ABL1 fusion protein, human
  • Biomarkers, Tumor
  • Core Binding Factor Alpha 2 Subunit
  • Neoplasm Proteins
  • RNA, Long Noncoding
  • RUNX1 protein, human
  • RUNX1-IT1 long non-coding RNA, human
  • Isocitrate Dehydrogenase
  • IDH1 protein, human
  • Fusion Proteins, bcr-abl